Ferring has announced the opening of the first clinical trial sites for 2 studies within the ABLE clinical trial program as well as the launch of the phase 1/2 LUNAR trial. “The combination of ...

“Our findings highlight the coordinated interplay between GCN2 and p53 regulation during nutrient stress and provide insight into how they could be targeted in developing new therapeutic strategies ...

IPP placement is associated with improved penile length and width ...

IPP placement is associated with improved penile length and width ...

IPP placement is associated with improved penile length and width ...

Would you please start by giving a brief overview of BCG-unresponsive NMIBC? Nonmuscle Invasive Bladder Cancer Prior to recent therapeutic innovations in the bladder space what challenges or unmet ...

Please review the standard treatment options (intravesical chemotherapy, PD-L1 inhibitors, other immunotherapeutic options) currently available for patients with BCG-unresponsive NMIBC.

"The interplay between the microbiome and bladder cancer is very complex," says Ilaha Isali, MD, MSc. Isali: The interplay between the microbiome and bladder cancer is very complex. There is still ...

Bayer seeks approval in China for darolutamide plus ADT for mHSPC, marking a potential third indication. The ARANOTE trial showed darolutamide plus ADT significantly improved rPFS and OS compared to ...

Quiz: CUA guidelines on germline genetic testing in prostate cancer ...

Quiz: CUA guidelines on germline genetic testing in prostate cancer ...